Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1135)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,437
Price
$568.33
Total Value
$816.69K
Shares Held After
41,870
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,280
Price
$567.45
Total Value
$1.29M
Shares Held After
43,307
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,117
Price
$566.33
Total Value
$1.20M
Shares Held After
45,587
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,811
Price
$565.34
Total Value
$1.02M
Shares Held After
47,704
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$564.11
Total Value
$205.90K
Shares Held After
49,515
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$563.01
Total Value
$74.88K
Shares Held After
49,880
% of Holdings
0.3%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,108
Price
$26.76
Total Value
$29.65K
Shares Held After
227,367
% of Holdings
0.5%
Seres Therapeutics, Inc. (MCRB)
Brady Kelly — Chief Operating Officer, EVP
Shares
59
Price
$7.53
Total Value
$444.27
Shares Held After
8,562
% of Holdings
0.7%
Seres Therapeutics, Inc. (MCRB)
Henn Matthew R — Chief Scientific Officer and EVP
Shares
77
Price
$7.53
Total Value
$579.81
Shares Held After
7,838
% of Holdings
1.0%
Seres Therapeutics, Inc. (MCRB)
Shaff Eric D. — Director
Shares
259
Price
$7.53
Total Value
$1.95K
Shares Held After
12,040
% of Holdings
2.1%
Seres Therapeutics, Inc. (MCRB)
DesRosier Thomas — EVP and Chief Legal Officer
Shares
79
Price
$7.53
Total Value
$594.87
Shares Held After
7,954
% of Holdings
1.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,032
Price
$26.76
Total Value
$27.62K
Shares Held After
143,934
% of Holdings
0.7%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,129
Price
$26.76
Total Value
$30.21K
Shares Held After
467,665
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
198
Price
$28.15
Total Value
$5.57K
Shares Held After
1,394,094
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
118,037
Price
$27.19
Total Value
$3.21M
Shares Held After
1,394,292
% of Holdings
7.8%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
60,000
Price
$16.88
Total Value
$1.01M
Shares Held After
96,928
% of Holdings
61.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,700
Price
$0.92
Total Value
$5.24K
Shares Held After
291,566
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
SULIMAN SHEHNAAZ — Director
Shares
5,740
Price
$25.12
Total Value
$144.19K
Shares Held After
27,951
% of Holdings
17.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
700
Price
$61.16
Total Value
$42.81K
Shares Held After
16,406
% of Holdings
4.1%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
800
Price
$60.34
Total Value
$48.27K
Shares Held After
17,106
% of Holdings
4.5%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,600
Price
$59.19
Total Value
$272.26K
Shares Held After
17,906
% of Holdings
20.4%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
4,190
Price
$58.34
Total Value
$244.47K
Shares Held After
22,506
% of Holdings
15.7%
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Soergel David — Chief Medical Officer
Shares
844
Price
$515.90
Total Value
$435.42K
Shares Held After
11,075
% of Holdings
7.1%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
3,000
Price
$18.76
Total Value
$56.28K
Shares Held After
3,622
% of Holdings
45.3%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.58
Total Value
$10.58K
Shares Held After
9,450
% of Holdings
10.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
4,643
Price
$92.21
Total Value
$428.13K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$20.74
Total Value
$1.04M
Shares Held After
1,122,626
% of Holdings
4.3%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
200
Price
$69.12
Total Value
$13.82K
Shares Held After
11,589
% of Holdings
1.7%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,512
Price
$68.23
Total Value
$103.16K
Shares Held After
11,789
% of Holdings
11.4%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
2,088
Price
$67.53
Total Value
$141.00K
Shares Held After
13,301
% of Holdings
13.6%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
6,200
Price
$66.69
Total Value
$413.46K
Shares Held After
15,389
% of Holdings
28.7%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
4,667
Price
$29.82
Total Value
$139.15K
Shares Held After
10,500
% of Holdings
30.8%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
5,333
Price
$29.83
Total Value
$159.09K
Shares Held After
15,167
% of Holdings
26.0%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
8,748
Price
$29.82
Total Value
$260.86K
Shares Held After
35,194
% of Holdings
19.9%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
10,000
Price
$29.92
Total Value
$299.16K
Shares Held After
45,111
% of Holdings
18.1%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
7,841
% of Holdings
23.5%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
15,345
% of Holdings
10.1%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
7,594
% of Holdings
18.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
456
Price
$72.67
Total Value
$33.14K
Shares Held After
105,212
% of Holdings
0.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2,356
Price
$72.08
Total Value
$169.82K
Shares Held After
105,668
% of Holdings
2.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
8,466
% of Holdings
23.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
8,011
% of Holdings
19.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,354
Price
$453.45
Total Value
$613.97K
Shares Held After
24,734
% of Holdings
5.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$6.28
Total Value
$261.61K
Shares Held After
1,774,781
% of Holdings
2.3%
Travere Therapeutics, Inc. (TVTX)
Coughlin Timothy — Director
Shares
3,250
Price
$43.49
Total Value
$141.34K
Shares Held After
52,250
% of Holdings
5.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
33
Price
$453.45
Total Value
$14.96K
Shares Held After
7,284
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
5,000
Price
$3.77
Total Value
$18.85K
Shares Held After
1,059,029
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
8,971
Price
$3.90
Total Value
$34.99K
Shares Held After
117,453
% of Holdings
7.6%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
5,000
Price
$20.70
Total Value
$103.50K
Shares Held After
43,415
% of Holdings
11.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$109.47
Total Value
$218.94K
Shares Held After
0
% of Holdings
100.0%
Showing 201–250 of 1135 transactions (page 5 of 23)